Abstracts

Rosuvastatin vs Protease Inhibitor Switch for Hypercholesterolemia: Randomised Trial

Background: Optimal management of hypercholesterolaemia in adults receiving a ritonavir-boosted protease inhibitor (rPI) is unknown. The two proven options, statin therapy and rPI switching to a lipid-neutral alternative, have not been compared since the advent of current-generation statins and PIs, despite multiple studies (mostly industry-sponsored) focussed upon rPI switching. Methods: Adults on rPI-based therapy with…

ICAM-1 Overexpression Induced by Abacavir is Mediated by P2X7 Receptors

Background: The use of abacavir has been associated with cardiovascular disease. In earlier studies, we have demonstrated that abacavir induces an increase in endothelial ICAM-1 expression and promotes leukocyte recruitment through Mac-1/ICAM-1 interaction. Given the chemical structure of abacavir, we have previously explored the link between abacavir and its proinflammatory effects by interfering in the…

Analysis of False Negative HIV Tests Based on Oral Fluid in 3 Clinical Trials

Background: The OraQuick Advance Rapid HIV-1/2 Antibody Test (OraSure, Bethlehem, PA) is a non-invasive, point-of-care, rapid HIV test capable of detecting HIV-specific antibodies in blood and oral fluid. The test is convenient and promises to increase HIV testing in at-risk populations. However, concerns regarding test sensitivity in oral fluid suggest that OraQuick Oral fluid (OQOF)…

Progression of Liver Disease in LHIV/HCV Coinfected People According to Gender in Icona Cohort: Role of Age as Potential Different Exposure to Estrogens

Background: Background: In HCV patients, female gender was reported as protective in liver fibrosis progression. However, post menopausal women show an increased rate of progression, suggesting a causative role of estrogens. Aim of the study was to evaluate the effect of age (proxy of menopausal status), on liver disease progression in a large HIV/HCV population.…

A Prognostic Score Estimating the Risk of Liver-Related Death Among HIV/HCV Coinfected Subjects

Background: Development of a simple, widely applicable prognostic score for liver-related death (LRD) among HIV/HCV coinfected individuals is essential to predict the future burden of LRD. An accurate prognostic score in this setting will aid comparison of individual risk profiles when prioritising who should be treated with new directly-acting antivirals for HCV. Methods: EuroSIDA patients…

Marijuana Use Does Not Accelerate Liver Fibrosis in HCV/HIV-Coinfected Women

Background: Cannabis (THC) use has been correlated with liver fibrosis progression in retrospective analyses of mono-infected chronic hepatitis C (HCV) patients, particularly in those with established fibrosis. We studied long-term effects of THC on fibrosis progression in women co-infected with HCV/HIV enrolled in Women’s Interagency HIV Study (WIHS), a prospective, multicenter, cohort of women with…